Belgium· BE-AMP-SAM186392-00
BeneFIX 250 IU
A nonacog alfa (rekombinanter blutgerinnungsfaktor ix) product containing nonacog alfa, registered in Belgium by Pfizer Europe MA. The same ATC class is registered in 2 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Nonacog alfa (rekombinanter blutgerinnungsfaktor ix) is registered in 2 of 19 countries.
Countries holding a registration under ATC B02BD09 (nonacog alfa (rekombinanter blutgerinnungsfaktor ix)), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 1 of them publish a price we can compare per daily dose
Nonacog alfa (rekombinanter blutgerinnungsfaktor ix) · ATC B02BD09
2 / 19 countries
- Belgiumprice
- Ireland
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Nonacog Alfa
- Manufacturer
- Pfizer Europe MA
- Country
- Belgium (BE)
- ATC code
- B02BD09
- ATC class
- Nonacog alfa (rekombinanter Blutgerinnungsfaktor IX)
- Defined daily dose
- 800 E, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nonacog alfa (rekombinanter blutgerinnungsfaktor ix) in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainBENEFIX 250 UI, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLEPfizer Europe Ma Eeig
- SwedenBeneFIX 250 IE Pulver och vätska till injektionsvätska, lösningPfizer Europe MA EEIG
- CzechiaBENEFIXPfizer Europe MA EEIG, Bruxelles
- FinlandBenefixPfizer Europe MA EEIG
- IrelandBeneFIX 1000 IU powder and solvent for solution for injectionPfizer Europe MA EEIG
- IcelandBeneFIXPfizer Europe MA EEIG*
- PolandBeneFixPfizer Europe MA EEIG
- FranceBENEFIX 1000 UI, poudre et solvant pour solution injectablePFIZER EUROPE MA EEIG (BELGIQUE)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Benefix, Rixubis
- Liechtenstein · Benefix, Rixubis
- Norway · Benefix, Rixubis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b38b669c-7ba8-40c2-afa5-96e481bb1480 GET /v1/drugs/b38b669c-7ba8-40c2-afa5-96e481bb1480?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "BeneFIX 250 IU",
"name_fr": "BeneFIX 250 IU",
"name_nl": "BeneFIX 250 IU",
"amp_code": "SAM186392-00",
"strengths": [
"250.0000"
],
"pack_count": 1,
"substances": [
"Nonacog Alfa"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Nonacog Alfa",
"authorisation_numbers": [
"EU/1/97/047/001"
]
}See everything about nonacog alfa (rekombinanter blutgerinnungsfaktor ix).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.